TIA: Updates and Management 2008

Similar documents
Advances in Prevention and Treatment of Stroke: What Every Primary Care Physician Needs to Know. Case 1 4/5/11. What treatment should you initiate?

2015 Update in Diagnosis and Management of Stroke

2018 Update in Diagnosis and Management of Stroke

2014 Update in Diagnosis and Management of Stroke

STROKE UPDATE ANTHEA PARRY MAY 2010

TIA triage in Not all that glitters is gold

Stroke Topics. Advances in the Prevention and Treatment of Stroke. Non-Contrast Head CT. Patient 1-68 yo man

Secondary Stroke Prevention

CEREBRO VASCULAR ACCIDENTS

Therapy for Acute Stroke. Systems of Care for TIA

Cryptogenic Strokes: Evaluation and Management

Alan Barber. Professor of Clinical Neurology University of Auckland

2/7/

TRANSIENT ISCHEMIC ATTACK (TIA)

Recent Advances in Neurology Difficult Cases

Alan Barber. Professor of Clinical Neurology University of Auckland

Cryptogenic Stroke: A logical approach to a common clinical problem

/ / / / / / Hospital Abstraction: Stroke/TIA. Participant ID: Hospital Code: Multi-Ethnic Study of Atherosclerosis

Management and Investigation of Ischemic Stroke By Etiology

David Strain, Diabetes and Vascular Research Centre University of Exeter Medical School, UK

KEEPING YOUR PATIENT OUT OF THE HOSPITAL BY PREVENTING A SECOND STROKE

How do we assess risk in TIA?

Dawn Matherne Meyer PhD,RN,FNP-C. Assistant Professor University of California San Diego

Stroke Update. Lacunar 19% Thromboembolic 6% SAH 13% ICH 13% Unknown 32% Hemorrhagic 26% Ischemic 71% Other 3% Cardioembolic 14%

[(PHY-3a) Initials of MD reviewing films] [(PHY-3b) Initials of 2 nd opinion MD]

Intracranial Atherosclerosis in Asians

Shawke A. Soueidan, MD. Riverside Neurology & Sleep Specialists

PFO Management update

Disclosures. An Update on TIA and Minor Stroke. The Agenda PROGNOSIS PATHOPHYSIOLOGY GUIDELINES AND PROVEN MANAGEMENT STRATEGIES AGGRESSIVE TREATMENT

TRAUMATIC CAROTID &VERTEBRAL ARTERY INJURIES

Unclogging The Pipes. Zahraa Rabeeah MD Chief Resident February 9,2018

5/2/2016. Outpatient Stroke Management Sheila Smith MD May 5, 2016

KEEPING YOUR PATIENT OUT OF THE HOSPITAL BY PREVENTING A SECOND STROKE OR TIA December 8, 2017

Canadian Best Practice Recommendations for Stroke Care. (Updated 2008) Section # 3 Section # 3 Hyperacute Stroke Management

Carotid Revascularization

Antithrombotic therapy in patients with transient ischemic attack / stroke (acute phase <48h)

Patent Foramen Ovale and Cryptogenic Stroke: Do We Finally Have Closure? Christopher Streib, MD, MS

Stroke/TIA. Tom Bedwell

Secondary Stroke Prevention: A Precautionary Tale

Neuroanatomy of a Stroke. Joni Clark, MD Professor of Neurology Barrow Neurologic Institute

Redgrave JN, Coutts SB, Schulz UG et al. Systematic review of associations between the presence of acute ischemic lesions on

Critical Review Form Therapy

Episode 117 TIA Update

Stroke in the ED. Dr. William Whiteley. Scottish Senior Clinical Fellow University of Edinburgh Consultant Neurologist NHS Lothian

Emergently? Michigan Institute for Neurological Disorders. Garden City Hospital, Garden City, Michigan

Michael Horowitz, MD Pittsburgh, PA

Disclosures. CREST Trial: Summary. Lecture Outline 4/16/2015. Cervical Atherosclerotic Disease

Section Editor Scott E Kasner, MD

2018 Early Management of Acute Ischemic Stroke Guidelines Update

Vague Neurological Conditions

Oltre la terapia medica nelle dissezioni carotidee

Document Title: The Management of Acute Ischemic Stroke & TIA

Nicolas Bianchi M.D. May 15th, 2012

Dr Julia Hopyan Stroke Neurologist Sunnybrook Health Sciences Centre

TIA Transient Ischaemic Attack?

It s Always a Stroke; Except For When It s Not..

Cryptogenic Stroke: What Don t We Know. Siddharth Sehgal, MD Medical Director, TMH Stroke Center Tallahassee Memorial Healthcare

TIA AND STROKE. Topics/Order of the day 1. Topics/Order of the day 2 01/08/2012


44TH ANNUAL RECENT ADVANCES IN NEUROLOGY

Carotid Artery Disease and What s Pertinent JOSEPH A PAULISIN DO

Stroke Workshop. Pre-Workshop Handout. With Walter Himmel, Meeta Patel & Anton Helman

How to Evaluate Patients with Cryptogenic Stroke

Guiding Secondary Stroke Prevention through Evaluation of Ischemic Stroke Etiology

Stroke: What did we learn in the last year?

ND STROKE Coordinators Case Studies. STEMI and Stroke Conference, Fargo, ND, August 5, 2014

Carotid Artery Stenting

Post-op Carotid Complications A Nursing Perspective of What to Watch Out for

Alan Barber. Professor of Clinical Neurology University of Auckland

Cerebrovascular Disorders. Blood, Brain, and Energy. Blood Supply to the Brain 2/14/11

Canadian Stroke Best Practices Initial ED Evaluation of Acute Stroke and Transient Ischemic Attack (TIA) Order Set (Order Set 1)

TCD in Subclavian Steal Syndrome

Practical Considerations in the Early Treatment of Acute Stroke

Non ST Elevation-ACS. Michael W. Cammarata, MD

GERIATRICS CASE PRESENTATION

Pharmacy STROKE. Anne Kinnear Lead Pharmacist NHS Lothian. Educational Solutions for Workforce Development

Stroke 101. Maine Cardiovascular Health Summit. Eileen Hawkins, RN, MSN, CNRN Pen Bay Stroke Program Coordinator November 7, 2013

Symptoms of small vessel strokes. Small Vessel stroke. What is this? Treatment. Large Vessel stroke 6/1/2018

Anticoagulants and Head Injuries. Asaad Shujaa,MD,FRCPC,FAAEM Assistant Professor,weill Corneal Medicne Senior Consultant,HMC Qatar

Session Antiplatelet Therapy: How, Why and When? In patients with ischemic stroke/tia

Internal Carotid Artery Dissection

ENCHANTED Era: Is it time to rethink treatment of acute ischemic stroke? Kristin J. Scherber, PharmD, BCPS Emergency Medicine Clinical Pharmacist

Department Specific Guideline

Advances in the treatment of posterior cerebral circulation symptomatic disease

MEET 2007: Evaluation and treatment of the stroke and TIA patient for the non-neurointerventionist. neurointerventionist

Primary Stroke Center Acute Stroke Transfer Guidelines When to Consider a Transfer:

THE FRAMINGHAM STUDY Protocol for data set vr_soe_2009_m_0522 CRITERIA FOR EVENTS. 1. Cardiovascular Disease

MD SUBTYPE ADJUDICATION VARIABLE DEFINITIONS MANUAL The following is a list of variables and how to complete each one:

Branko N Huisa M.D. Assistant Professor of Neurology UNM Stroke Center

Supplementary material 1. Definitions of study endpoints (extracted from the Endpoint Validation Committee Charter) 1.

Overview INTRODUCTION 3/15/2018. Headache Emergencies. Other way to differentiate between them? Is there an easy way to differentiate between them?

Evaluation of the Dizzy Patient

Management of intracranial atherosclerotic stenosis (ICAS)/intracranial atherosclerosis

Carotid Stenosis 1/24/2019. Review of Primary Studies. NASCET- Moderate stenosis. ACAS (Asymptomatic Carotid Atherosclerosis Study) NASCET

OHSU HEALTH CARE SYSTEM PRACTICE GUIDELINES

La terapia antiaggregante nel paziente con stroke

Management of cervicocephalic arterial dissection. Ciro G. Randazzo, MD, MPH Thomas Jefferson University Hospital, Department of Neurosurgery

Permanent foramen ovale: when to close?

Brain Attack. Strategies in the Management of Acute Ischemic Stroke: Neuroscience Clerkship. Case Medical Center

Transcription:

TIA: Updates and Management 2008 S. Andrew Josephson, MD Department of Neurology, Neurovascular Division University of California San Francisco Commonly Held TIA Misconceptions TIA is easy to diagnose using modern imaging modalities and laboratories TIA and stroke are distinct entities The natural history of TIA is benign Urgent treatment of TIA is of no proven benefit The speaker has no disclosures Case 1 A 67 year-old woman with a history of HTN presented to the ED after an unwitnessed 20 minute episode of left arm weakness that has since resolved. Her examination is normal. What is the most likely etiology of this spell? 1. TIA 2. Migraine 3. Partial Seizure 4. Porphyria 5. Conversion Disorder 1

Case 1 (con t) Within 30 minutes of the MRI, the patient experienced a witnessed spell of rhythmic shaking of the L arm followed by an extended period of paralysis. Chest X-Ray reveals large mass consistent with adenocarcinoma. Differential for Transient Focal Neurologic Deficit TIA Definition: A transient neurologic deficit attributable to a vascular cause that resolves completely within 24 hours (most are only minutes). The Big Three 1. Stroke/TIA 2. Seizure 3. Complicated Migraine Proven Markers of Migraine Motion Sickness Brain Freeze Headaches that occur at regular times related to the menstrual cycle Pain triggered by smells or repetitive noises Cyclic abdominal pain as a child Diagnosis of TIA Purely a clinical diagnosis No laboratory troponin for the brain No imaging study confirms or refutes Even experts don t agree (kappa=0.65) When in doubt, assume it is a TIA False positives are acceptable in this instance! Kraaijeveld CL Stroke 1984 2

Case 2 A 40 year-old man with no PMH comes to the ED after a 30 minute episode of aphasia and right arm weakness that has since resolved. The patient reports 5 days of neck pain after severe vomiting from a gastroenteritis Exam is normal What is the most likely etiology of this TIA? 1. Atrial Fibrillation-Related Embolus 2. Carotid Dissection 3. Small-Vessel Atherosclerosis 4. Endocarditis 5. Hypercoagulable State UCSF Stroke Protocol CT Obtained at UCSF in all suspected acute stroke and TIA patients 1. Non-contrast CT of the head 2. CT Angiography from aortic arch/heart through Circle of Willis 3. CT Perfusion study 4. Post-contrast CT of the head MRI in TIA Diffusion-weighted MR imaging very useful in stroke to distinguish from mimics In TIA, about 50% of patients will have infarction on MRI As duration of spell increases, so does percentage with infarction But not beyond 50-60% 3

MRI in TIA Therefore.. 1. The distinction between TIA and stroke is quite artificial 2. MRI looking for infarction is not a useful test to exclude the diagnosis of TIA Approach to Stroke/TIA Treatment Acute Stroke Therapy? No Anticoagulants? No Antiplatelets Shrinking Indications for Anticoagulation in Stroke 1. Atrial Fibrillation 2. Some other cardioembolic sources Thrombus seen in heart?ef<35?pfo with associated Atrial Septal Aneurysm 3. Vertebral and carotid artery dissection 4. Rare hypercoagulable states: APLA Cervical Artery Dissection Vertebral and Carotid Arteries Common etiology of stroke in young Pathophysiology Risk Factors Most idiopathic Vomiting, Coughing, Chiropractic Presentation: Neck Pain, HA Tx with anticoagulation Courtesy Wade Smith, MD, PhD 4

Case 3 A 65 year-old man with diabetes comes to the ED after 15 minutes of L arm weakness and slurred speech that has now resolved. Vitals: BP 160/80, HR 67, sat 100%, RR 12 Exam is normal What is the approximate 90-day stroke risk for this patient? 1. 1 percent 2. 5 percent 3. 15 percent 4. 50 percent 5. 80 percent Risk of Future Stroke with TIA: ABCD 2 Score Age >60 =1 point Blood Pressure SBP>140 or DBP>90 =1 point Clinical Features Unilateral weakness =2 points Speech disturbance without weakness =1 point Duration >60 minutes =2 points 10-59 minutes =1 point Diabetes=1 point Johnston SC, Lancet 2007 ABCD 2 Score 7-day risk overall 8.6-10.5 percent 2-day risk of stroke Score 6-7: 8.1 percent (high risk) Score 4-5: 4.1 percent (moderate risk) Score 0-3: 1.0 percent (low risk) Johnston SC, Lancet 2007 5

ABCD 2 Score: Common Sense? 1707 patients seen in the ED with TIA in Northern California before prediction rules were published Did ABCD 2 score correlate with decision to admit for further workup and treatment? No, only weak correlation (R 2 =0.036) Factors associated with admission had little relationship with factors in ABCD 2 score ABCD 2 Score: How Does It Work? The same 1707 patients seen in the ED with TIA in Northern California before prediction rules were published Expert neurologist reviewed all records retrospectively (ED and inpatient) to decide if event was a true TIA. ABCD 2 score was higher in those with true TIA Perhaps ABCD 2 partially works by identifying those with true TIA as opposed to alternative dx Josephson SA Stroke 2008 Josephson SA Stroke 2008 Appropriate TIA Workup and Treatment Imaging Workup of TIA All patients require head imaging, mainly to exclude mimics Non-contrast CT best, MR adds little value Enhanced CT/MR techniques provide further important information Vascular Imaging of Head and Neck 6

Vascular Imaging Utility: Case 4 A 70 year-old man with HTN, diabetes comes to the ED after 30 minutes of L arm weakness that has now resolved Large Vessel Occlusions Predict a poor outcome in Stroke and TIA patients Permissive (or induced) HTN is key in these patients to prevent further injury Likely mandates close observation Consideration should be given to intervention if the patient worsens Vascular Imaging Utility: Case 5 A 68 year-old woman with a history only of HTN presents with daily episodes of right eye blindness that completely resolve after 3 to 15 minutes. Exam is normal including fundoscopy Carotid Stenosis and TIA Along with afib, one of two etiologies of stroke/tia with the strongest evidence for intervention to prevent subsequent events Consensus guidelines urge urgent revascularization of symptomatic lesions Guidelines: After stroke, within 2 weeks TIA Experience: Within hours to days Chaturvedi S, Neurology 2005 7

Standard TIA/Stroke Workup Cardioembolic: afib, clot in heart, paradoxical embolus 1. Telemetry 2. Echo with bubble study Aortic Arch 2. Echo with bubble study Carotids 3. Carotid Imaging (CTA, US, MRA, angio) Intracranial Vessels 4. Intracranial Imaging (CTA, MRA, angio) Case 6 A 55 year-old woman with a hx of smoking presents after 1-hour of R leg weakness that has since resolved. Her only medication at home is ASA 81mg daily. Exam is normal. And evaluate stroke risk factors What is the appropriate secondary prevention medication for this pt? 1. Coumadin 2. ASA 325mg 3. Clopidogrel (Plavix) 4. 25mg ASA/200mg ER Dipyridamole (Aggrenox) 5. Nimodipine Approach to Stroke/TIA Treatment Acute Stroke Therapy? No Anticoagulants? No Antiplatelets 8

Antiplatelet Options 1. ASA 50mg to 1.5g equal efficacy long-term 2. Aggrenox 25mg ASA/200mg ER Dipyridamole ESPS-2, ESPRIT (Lancet 5/06) 3. Clopidogrel (Plavix) MATCH (Lancet 7/04) FASTER (Lancet Neurol 10/07) Aggrenox vs. Plavix Aggrenox Headache in first 2 weeks: 30% discontinue Perhaps not compatible with cardiac antiplatelet goals or with unstable angina Cannot be crushed in FT Plavix Less evidence directly from stroke trials Concerns regarding use with ASA PRoFESS trial results announced May 2008 PRoFESS Trial (NEJM 9/08) Randomized, double-blind trial of Aggrenox versus Plavix in over 20,000 patients with ischemic stroke (many very minor) Recurrent 4-year event rates basically identical between the two medications HR for Aggrenox 1.01 (95% CI, 0.92-1.11) Composite of stroke, MI, vascular death: 13.1% in each Major hemorrhagic events higher in Aggrenox group Antiplatelet Options If on no antiplatelet medication ASA or Plavix vs. Aggrenox If already on ASA Switch to Plavix vs. Aggrenox Note: There is no acute data for Aggrenox If already on Plavix or Aggrenox??? 9

Which of the following TIA patients are you most likely to admit? 1. 40F with DM following a 5-minute episode of aphasia 2. 85M with HTN (bp 160/90) and afib with 15 minutes of R arm weakness 3. 70M with HTN (bp 160/90), DM with 20 minutes of R leg weakness Which of the following TIA patients are you most likely to admit? 1. ABCD 2 =2 2. ABCD 2 =5 3. ABCD 2 =6 Is Urgent Evaluation of TIA Helpful or Necessary? To complete workup? To initiate secondary prevention strategies? Only for high-risk patients? To allow for t-pa to be given quickly if symptoms return? Until 2007, absolutely no evidence SOS-TIA Study: October 2007 1085 patients with TIA admitted to a 24- hour clinic (basically an inpatient center) All treated with standard therapy 74 percent discharged on same day 90-day stroke rate reduced by 80% compared with that predicted by ABCD 2 (5.96% to 1.24%) Lavallee PC Lancet Neurology 2007 10

EXPRESS Study: October 2007 Prospective before and after trial of patients with TIA or minor stroke Referral from ED to urgent assessment at a daily TIA clinic rather than waiting for PMD appointment Work-up completed, secondary prevention begun in clinic Reduced 90-day risk of recurrent stroke by 80% (10.3% to 2.1%, HR 0.20, 95% CI 0.08-0.49, p=0.0001) Take-Home Points TIA is a neurologic emergency Our version of unstable angina TIA is a purely clinical diagnosis If you think it s a TIA, it is The distinction between TIA and stroke is completely artificial TIA should be treated and worked up just like an ischemic stroke Rothwell PM, Lancet 2007 Take-Home Points Risk of subsequent stroke after TIA can be predicted with a high degree of accuracy Urgent evaluation and treatment of TIA patients substantially reduces this risk Whether this evaluation should occur in an inpatient setting or ultra-rapid outpatient clinic is dependent on the health care system involved 11